Alerts will be sent to your verified email
Verify EmailCOLINZ
Colinz Laboratories
|
Link Pharma Chem
|
Saroja Pharma Ind
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
4.05 % | 4.87 % | 33.33 % |
5yr average Equity Multiplier
|
1.3 | 1.96 | 4.66 |
5yr Average Asset Turnover Ratio
|
0.7 | 1.37 | 2.98 |
5yr Avg Net Profit Margin
|
4.66 % | 1.5 % | 2.08 % |
Price to Book
|
1.6 | 1.17 | 0.0 |
P/E
|
31.43 | 0.0 | 16.39 |
5yr Avg Cash Conversion Cycle
|
-0.66 Days | 74.76 Days | 80.28 Days |
Inventory Days
|
64.79 Days | 54.27 Days | 11.27 Days |
Days Receivable
|
51.75 Days | 53.6 Days | 122.72 Days |
Days Payable
|
78.66 Days | 92.46 Days | 47.62 Days |
5yr Average Interest Coverage Ratio
|
9.16 | 3.51 | 2.76 |
5yr Avg ROCE
|
6.01 % | 8.64 % | 37.65 % |
5yr Avg Operating Profit Margin
|
6.82 % | 5.7 % | 4.76 % |
5 yr average Debt to Equity
|
0.07 | 0.46 | 1.78 |
5yr CAGR Net Profit
|
30.39 % | n/a | 3.81 % |
5yr Average Return on Assets
|
3.14 % | 2.49 % | 6.13 % |
Shareholdings
|
|||
Promoter Holding
|
65.94 % | 51.49 % | 73.02 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
29.56 % | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Colinz Laboratories
|
Link Pharma Chem
|
Saroja Pharma Ind
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|